Acute generalized exanthematous pustulosis associated with clindamycin in a patient with Hailey-Hailey disease
- PMID: 37430411
- DOI: 10.1111/cup.14488
Acute generalized exanthematous pustulosis associated with clindamycin in a patient with Hailey-Hailey disease
Abstract
A 61-year-old African-American female with moderately controlled Hailey-Hailey disease (HHD) presents to the emergency department with a rash and fever. One day prior to her presentation, she was started on oral clindamycin for a tooth extraction procedure. Her physical examination shows diffuse erythema on the trunk and extremities with multiple nonfollicular pustules. A punch biopsy of her upper extremity revealed intraepidermal acantholysis, neutrophilic spongiosis, and subcorneal pustules. The perivascular and interstitial superficial dermal infiltrate is mixed and composed of predominantly neutrophils, with lymphocytes and rare eosinophils. These findings suggest a superimposed acute generalized exanthematous pustulosis (AGEP) in the background of HHD. AGEP is a potentially severe cutaneous condition characterized by the abrupt onset of numerous nonfollicular pustules in a background of pruritic edematous erythroderma. To date, only two case reports have described AGEP in patients with HHD. Early diagnosis of AGEP is essential to initiate prompt and aggressive systemic therapy, prompt medication cessation, close monitoring for end-organ damage, and improve overall morbidity and mortality.
Keywords: Hailey-Hailey disease (HHD); acute generalized exanthematous pustulosis (AGEP); clindamycin; pustular dermatosis.
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Koebnerization of Hailey-Hailey disease into a cutaneous drug eruption of acute generalized exanthematous pustulosis associated with systemic symptoms.J Cutan Pathol. 2016 Nov;43(11):1031-1035. doi: 10.1111/cup.12771. Epub 2016 Aug 22. J Cutan Pathol. 2016. PMID: 27433827
-
Clinical characteristics, treatment and outcome of clindamycin induced acute generalized exanthematous pustulosis.Arch Dermatol Res. 2024 Aug 24;316(8):573. doi: 10.1007/s00403-024-03310-8. Arch Dermatol Res. 2024. PMID: 39180541
-
Clindamycin-induced acute generalized exanthematous pustulosis: A case report.Medicine (Baltimore). 2020 May 22;99(21):e20389. doi: 10.1097/MD.0000000000020389. Medicine (Baltimore). 2020. PMID: 32481338 Free PMC article.
-
Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis.J Am Acad Dermatol. 2022 Sep;87(3):632-639. doi: 10.1016/j.jaad.2020.09.024. Epub 2020 Sep 11. J Am Acad Dermatol. 2022. PMID: 32926975 Review.
-
Acute generalized exanthematous pustulosis (AGEP): A review and update.J Am Acad Dermatol. 2015 Nov;73(5):843-8. doi: 10.1016/j.jaad.2015.07.017. Epub 2015 Sep 6. J Am Acad Dermatol. 2015. PMID: 26354880 Review.
References
REFERENCES
-
- Tamir E, Wohl Y, Mashiah J, Brenner S. Acute generalized exanthematous pustulosis: a retrospective analysis showing a clear predilection for women. Skinmed. 2006;5(4):186-188. doi:10.1111/j.1540-9740.2006.05019.x
-
- Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP)-a clinical reaction pattern. J Cutan Pathol. 2001;28(3):113-119. doi:10.1034/j.1600-0560.2001.028003113.x
-
- Thienvibul C, Vachiramon V, Chanprapaph K. Five-year retrospective review of acute generalized exanthematous pustulosis. Dermatol Res Pract. 2015;2015:260928. doi:10.1155/2015/260928
-
- De A, Das S, Sarda A, Pal D, Biswas P. Acute generalised exanthematous pustulosis: an update. Indian J Dermatol. 2018;63(1):22-29. doi:10.4103/ijd.IJD_581_17
-
- Creadore A, Desai S, Alloo A, et al. Clinical characteristics, disease course, and outcomes of patients with acute generalized exanthematous pustulosis in the US. JAMA Dermatol. 2022;158(2):176-183. doi:10.1001/jamadermatol.2021.5390
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical